Santen Pharmaceutical Home Page

Investor Relations

Select region

Santen Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing and marketing of ophthalmic and anti-rheumatic pharmaceuticals to protect and improve people's eyesight and health. More details...

What's New
Mar 10, 2010	Change of management positions at Santen Inc.
Mar 10, 2010	Notice of the appointment of Corporate Officers
Mar 2, 2010	Banyu and Santen Announce Co-Promotion Agreement for Combination Ophthalmic Solution, Treatment for Glaucoma and Ocular Hypertension
Mar 2, 2010	Santen Files Manufacturing/Marketing Approval of its Broad Spectrum Anti-Infective Ophthalmic Solution DE-108 (Generic name: Levofloxacin, high concentration)
Feb 2, 2010	Santen Announces Financial Result for the Third Quarter ended December 31, 2009
News list

For Shareholders and Investors


	Annual Report

	Santen Brief History